Juliette Hughes

Lecturer of Anatomy

University of Liverpool

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Juliette Hughes is a Lecturer of Anatomy at the University of Liverpool, United Kingdom. Her research focuses on alkaptonuria and its implications on joint health, including anatomical investigations and metabolomic studies. Dr. Hughes has contributed to understanding tyrosine metabolism and the biochemical pathways related to hereditary tyrosinemia. She is actively involved in exploring innovative treatments and their efficacy for patients with metabolic disorders.

Articles (11)

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Haaike Colemonts-Vroninks

Vrije Universiteit Brussel

BELGIUM

View details

Joery De Kock

Vrije Universiteit Brussel

BELGIUM

View details

Sien Lequeue

Vrije Universiteit Brussel

BELGIUM

View details

George Bou-Gharios

Professor of Matrix Biology

University of Liverpool

UNITED KINGDOM

View details

Jessie Neuckermans

Vrije Universiteit Brussel

BELGIUM

View details

Craig Keenan

Academic, Senior Lecturer - Medical School

Edge Hill University

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Juliette Hughes

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

An anatomical investigation of alkaptonuria: Novel insights into ochronosis of cartilage and bone

Joint replacement risk is markedly increased in alkaptonuria (AKU) in those with prior arthroplasty

Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype

Comprehensive Biotransformation Analysis of Phenylalanine-Tyrosine Metabolism Reveals Alternative Routes of Metabolite Clearance in Nitisinone-Treated Alkaptonuria

Anatomical Distribution of Ochronotic Pigment in Alkaptonuric Mice is Associated with Calcified Cartilage Chondrocytes at Osteochondral Interfaces

Expression of tyrosine pathway enzymes in mice demonstrates that homogentisate 1,2‐dioxygenase deficiency in the liver is responsible for homogentisic acid‐derived ochronotic pigmentation

Metabolomic studies in the inborn error of metabolism alkaptonuria reveal new biotransformations in tyrosine metabolism

Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial

Studies in alkaptonuria reveal new roles beyond drug clearance for phase I and II biotransformations in tyrosine metabolism

Dietary restriction of tyrosine and phenylalanine lowers tyrosinemia associated with nitisinone therapy of alkaptonuria

Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuria

Collaborators (6)

Haaike Colemonts-Vroninks

Joery De Kock

Sien Lequeue

George Bou-Gharios

Jessie Neuckermans

Craig Keenan

Make your next move.